Dermata Therapeutics Statistics

Total Valuation

DRMA has a market cap or net worth of $5.97 million. The enterprise value is $3.25 million.

Market Cap	5.97M
Enterprise Value	3.25M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

DRMA has 5.43 million shares outstanding. The number of shares has increased by 684.79% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+684.79%
Shares Change (QoQ)	+121.05%
Owned by Insiders (%)	19.84%
Owned by Institutions (%)	5.33%
Float	4.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.90
P/TBV Ratio	4.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.79

Current Ratio	1.79
Quick Ratio	1.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -310.44% and return on invested capital (ROIC) is -197.59%.

Return on Equity (ROE)	-310.44%
Return on Assets (ROA)	-135.87%
Return on Invested Capital (ROIC)	-197.59%
Return on Capital Employed (ROCE)	-801.57%
Revenue Per Employee	n/a
Profits Per Employee	-$1.54M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.99% in the last 52 weeks. The beta is 0.65, so DRMA's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-79.99%
50-Day Moving Average	1.21
200-Day Moving Average	1.59
Relative Strength Index (RSI)	46.08
Average Volume (20 Days)	4,073,918

Short Selling Information

The latest short interest is 188,842, so 3.48% of the outstanding shares have been sold short.

Short Interest	188,842
Short Previous Month	247,650
Short % of Shares Out	3.48%
Short % of Float	4.73%
Short Ratio (days to cover)	1.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.51M
Pretax Income	-9.82M
Net Income	-12.29M
EBITDA	n/a
EBIT	-12.51M
Earnings Per Share (EPS)	-$8.03

Full Income Statement

Balance Sheet

The company has $3.16 million in cash and n/a in debt, giving a net cash position of $3.16 million or $0.58 per share.

Cash & Cash Equivalents	3.16M
Total Debt	n/a
Net Cash	3.16M
Net Cash Per Share	$0.58
Equity (Book Value)	1.56M
Book Value Per Share	0.62
Working Capital	1.56M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-684.79%
Shareholder Yield	n/a
Earnings Yield	-191.75%
FCF Yield	n/a

Analyst Forecast

The average price target for DRMA is $6.00, which is 445.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	445.46%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 16, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 16, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1